PHI with Chronic polyarthritis
How does this condition affect your private health insurance?
Chronische Polyarthritis, commonly known as Rheumatoid Arthritis (RA), is a systemic autoimmune disease primarily attacking the synovial lining of joints, leading to inflammation, pain, swelling, and stiffness. It typically affects multiple joints symmetrically, often starting in the small joints of hands and feet. Over time, it can cause severe joint destruction, deformities, and functional disability. Beyond joints, RA can impact various organs, including the lungs, heart, and eyes, and presents with systemic symptoms like fatigue. While no cure exists, early diagnosis and aggressive management with disease-modifying antirheumatic drugs (DMARDs) and biologics are crucial to control inflammation, prevent joint damage, and improve quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for initial symptoms and diagnosis.
Duration of Illness (Lifetime)
Chronic disease, requiring lifelong management.
Cost of Treatment (Initial)
Several hundreds to thousands of euros/dollars for diagnosis and initial treatment (consultations, tests, initial medications).
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of euros/dollars over a lifetime, including ongoing medication (DMARDs, biologics), specialist visits, physical therapy, and potential surgeries.
Mortality Rate
Low directly, but severe cases increase risk of complications (e.g., cardiovascular disease, infections) which can reduce life expectancy by 5-10 years.
Risk of Secondary Damages
High; includes joint destruction and deformity, chronic pain, functional disability, cardiovascular disease, interstitial lung disease, osteoporosis, and psychological impact (depression, anxiety).
Probability of Full Recovery
Very low; while remission is achievable with treatment, complete recovery without any long-term consequences or need for ongoing management is rare for this chronic autoimmune condition.
Underlying Disease Risk
High; increased risk for cardiovascular diseases, osteoporosis, interstitial lung disease, Sjögren's syndrome, and depression.